No One Fights Alone
Dr. Sacher
Lung cancer is the leading cause of cancer-related death both in Canada and around the world. Each year, more people die from lung cancer than breast, colon and prostate cancer combined. It is a disease with the potential to affect all of us as we are increasingly recognizing that the only prerequisite for lung cancer is to have a pair of lungs. Lung cancer receives a disproportionately small amount of research funding with only 7% of government funding allocated to lung cancer and less than 0.1% of philanthropic donations. Despite being an underfunded and often misunderstood cancer, recent research has led to dramatic changes in the treatment of lung cancer including advances in new immunotherapies and targeted therapies. Donations to support lung cancer research are key to furthering these advances and providing hope to the many patients and their families living with lung cancer.
Dr. Sacher is a Thoracic Oncologist & Affiliate Scientist at the Princess Margaret Cancer Centre and an Assistant Professor in the Departments of Medicine & Immunology at the University of Toronto. Dr. Sacher completed his medical degree at the University of Toronto and residency at the Toronto General Hospital and Princess Margaret Cancer Center. He has subsequently completed a research fellowship in thoracic oncology at the Dana-Farber Cancer Institute and holds a Master’s degree in clinical trial design, genomics and drug development from Harvard Medical School. He has previously served as an Assistant Professor of Medicine and Attending Thoracic Oncologist at Columbia University & New York-Presbyterian Hospital. He has been awarded an American Society of Clinical Oncology (ASCO) Career Development Award (CDA) and Canadian Institutes for Health Research (CIHR) Project Grant for his work on tumor immunotherapy.
